Mitotane - CAS 53-19-0
Catalog number:
53-19-0
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C14H10Cl4
Molecular Weight:
320.04
COA:
Inquire
Targets:
Others
Description:
Mitotane, is an antineoplastic medication used in the treatment of adrenocortical carcinoma.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
NCI-C04933
MSDS:
Inquire
1.Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.
Elfiky AA1, Krishnan Nair HK1. Discov Med. 2016 Jan;21(113):49-56.
Within the category of orphan diseases and rare malignancies, adrenocortical carcinoma (ACC) represents an aggressive entity with high mortality and morbidity. While localized tumors which are diagnosed early can be cured with surgical intervention, there are prognostic factors which predict for micrometastases and consequent recurrent and advanced disease. In such cases, cytotoxic chemotherapy and mitotane have been utilized with a very modest degree of benefit. The poor prognosis of recurrent and advanced ACC has underscored the interest in nuanced characterization of ACC cases using next-generation sequencing (NGS)-based genomic and other '-omic' profiling to guide the precision medicine approach and personalized use of targeted and novel therapies.
2.Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy: Case Report and Review of the Literature.
Ghorayeb NE1, Rondeau G, Latour M, Cohade C, Olney H, Lacroix A, Perrotte P, Sabourin A, Mazzuco TL, Bourdeau I. Medicine (Baltimore). 2016 Mar;95(13):e3180. doi: 10.1097/MD.0000000000003180.
Mitotane has been used for more than 5 decades as therapy for adrenocortical carcinoma (ACC). However its mechanism of action and the extent of tumor response remain incompletely understood. To date no cases of rapid and complete remission of metastatic ACC with mitotane monotherapy has been reported.A 52-year-old French Canadian man presented with metastatic disease 2 years following a right adrenalectomy for stage III nonsecreting ACC.He was started on mitotane which was well tolerated despite rapid escalation of the dose. The patient course was exceptional as he responded to mitotane monotherapy after only few months of treatment. Initiation of chemotherapy was not needed and he remained disease-free with good quality of life on low maintenance dose of mitotane during the following 10 years. A germline heterozygous TP53 exon 4 polymorphism c.215C>G (p. Pro72Arg) was found. Immunohistochemical stainings for IGF-2 and cytoplasmic β-catenin were positive.
3.The adrenal specific toxicant mitotane directly interacts with lipid membranes and alters membrane properties depending on lipid composition.
Scheidt HA1, Haralampiev I2, Theisgen S1, Schirbel A3, Sbiera S4, Huster D1, Kroiss M4, Müller P5. Mol Cell Endocrinol. 2016 Mar 18. pii: S0303-7207(16)30070-3. doi: 10.1016/j.mce.2016.03.022. [Epub ahead of print]
Mitotane (o,p'.-DDD) is an orphan drug approved for the treatment of adrenocortical carcinoma. The mechanisms, which are responsible for this activity of the drug, are not completely understood. It can be hypothesized that an impact of mitotane is mediated by the interaction with cellular membranes. However, an interaction of mitotane with (lipid) membranes has not yet been investigated in detail. Here, we characterized the interaction of mitotane and its main metabolite o,p'-dichlorodiphenyldichloroacetic acid (o,p'-DDA) with lipid membranes by applying a variety of biophysical approaches of nuclear magnetic resonance, electron spin resonance, and fluorescence spectroscopy. We found that mitotane and o,p'-DDA bind to lipid membranes by inserting into the lipid-water interface of the bilayer. Mitotane but not o,p'-DDA directly causes a disturbance of bilayer structure leading to an increased permeability of the membrane for polar molecules.
4.Adrenocortical carcinoma: Retrospective analysis of the last 22 years.
Guelho D1, Paiva I2, Vieira A3, Carrilho F2. Endocrinol Nutr. 2016 Mar 8. pii: S1575-0922(16)00024-3. doi: 10.1016/j.endonu.2015.12.009. [Epub ahead of print]
BACKGROUND: Adrenocortical carcinoma (ACC) is a rare disease with a poor prognosis. The clinical experience acquired, even from a small number of cases, has improved understanding of this condition. The purpose of this study is to characterize patients with ACC followed up at a Portuguese reference center over the past 22 years.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


PD 130908
(CAS: 131505-02-7)

PD 130908 is an effective hypoxic cytotoxin as an analogue of RSU 1069, but less potent than the hypoxic cell radiosensitizer RSU 1069. Toxicity toward hypoxic ...

CAS 947669-91-2 WWL70

WWL70
(CAS: 947669-91-2)

WWL70 is a potent inhibitor of α/β-hydrolase domain 6 (ABHD6) (IC50 = 70 nM). ABHD6 is a serine hydrolase that is highly expressed in mammalian brain.

CAS 4969-02-2 Metixene

Metixene
(CAS: 4969-02-2)

Metixene is an anticholinergic used as an antiparkinsonian agent for the symptomatic treatment of parkinsonism.

CAS 304-20-1 Hydralazine hydrochloride

Hydralazine hydrochloride
(CAS: 304-20-1)

Hydralazine HCl is a hydrochloride salt of hydralazine (Apresoline) that is a direct-acting smooth muscle relaxant with an IC50 of 1.9 mM.

CAS 103-86-6 4-(2-aminopropyl)phenol

4-(2-aminopropyl)phenol
(CAS: 103-86-6)

Hydroxyamphetamine, an active metabolite product of amphetamine, is a prescription drug that could stimulate the sympathetic nervous system and commonly be used...

CAS 1018675-35-8 CVT-12012

CVT-12012
(CAS: 1018675-35-8)

CVT-12012 is a bio-active chemical compound and is highly potent in a human cell-based (HEPG2) SCD assay with IC50 value of 6nM.

CAS 41177-35-9 CS 476

CS 476
(CAS: 41177-35-9)

AT-308 is a synthetic bio-active chemical as an oral hypoglycaemic agent.

CAS 525-79-1 Kinetin

Kinetin
(CAS: 525-79-1)

Kinetin is a type of cytokinin, a class of plant hormone that promotes cell division.

CAS 55981-09-4 Nitazoxanide

Nitazoxanide
(CAS: 55981-09-4)

Nitazoxanide is a synthetic nitrothiazolyl-salicylamide derivative and an antiprotozoal agent. (IC50 for canine influenza virus ranges from 0.17 to 0.21 μM)

CAS 1821428-35-6 AZD0156

AZD0156
(CAS: 1821428-35-6)

AZD0156 is an orally active, potent and selective ataxia telangiectasia mutated (ATM) kinase inhibitor, used for cancer treatment. AZD0156 prevents DNA damage c...

CAS 155488-25-8 Sograzepide

Sograzepide
(CAS: 155488-25-8)

Sograzepide, a benzodiazepin derivative, has been found to be a gastric receptor as well as CCK2 receptor antagonist that could be useful against chronic atroph...

CAS 22033-87-0 TRO 19622

TRO 19622
(CAS: 22033-87-0)

Olesoxime (TRO19622) is an experimental neuroprotective drug. It is the lead compound of Trophos' cholesterol-oxime compound family of mitochondrial pore modula...

Droxicainide hydrochloride
(CAS: 149572-05-4)

The hydrochloride salt form of Droxicainide, a piperidine derivative, has been found to be an potential antiarrhythmic agent.

CAS 603148-36-3 Azeliragon

Azeliragon
(CAS: 603148-36-3)

Azeliragon is a potent and orally active RAGE inhibitor as a potential treatment for patients with mild-to-moderate Alzheimer's disease (AD).

CAS 36341-25-0 YL-109

YL-109
(CAS: 36341-25-0)

Mice treated with vehicle showed significantly enlarged tumors, whereas mice treated with YL-109 showed attenuated tumor growth using MCF-7 cells. Interestingly...

GYKI-23107
(CAS: 83843-49-6)

GYKI-23107 is an antiarrhythmic agent with local anaesthetic activity.

CAS 132-69-4 Benzydamine Hydrochloride

Benzydamine Hydrochloride
(CAS: 132-69-4)

Benzydamine hydrochlorid is structurally unrelated to the corticosteroids. The action of benzydamine may be mediated by the prostaglandin system.

BMS 433771
(CAS: 380603-10-1)

BMS 433771 is a potent inhibitor of RSV replication in vitro with an average EC of 20nM

CAS 1867-73-8 N6-methyladenosine

N6-methyladenosine
(CAS: 1867-73-8)

N6-Methyladenosine is an abundant modification in mRNA and is found within some viruses, and most eukaryotes including mammals, insects, plants and yeast.

CAS 53-06-5 Cortisone

Cortisone
(CAS: 53-06-5)

Cortisone is a synthetic steroid hormone which are widely used for the treatment of inflammation; a corticosterone analog that has approximately twice the anti-i...

Chemical Structure

CAS 53-19-0 Mitotane

Quick Inquiry

Verification code

Featured Items